ATE534394T1 - Kombination aus einem magnesiumpräparat mit verlängerter freisetzung und spezifischen pflanzenextrakten und verwendung in den bereichen kosmetik, therapeutika und/oder ernährung - Google Patents

Kombination aus einem magnesiumpräparat mit verlängerter freisetzung und spezifischen pflanzenextrakten und verwendung in den bereichen kosmetik, therapeutika und/oder ernährung

Info

Publication number: ATE534394T1
Authority: AT; Austria
Prior art keywords: sub; cosmetics; plant extracts; combination; nutritional
Prior art date: 2003-05-27

Application number

AT04767183T

Other languages

English (en)

Inventor

Menvielle-Bourg Fabienne Joanny

Original Assignee

Menvielle-Bourg Fabienne Joanny

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-27

Filing date

2004-05-26

Publication date

2011-12-15

2004-05-26 Application filed by Menvielle-Bourg Fabienne Joanny filed Critical Menvielle-Bourg Fabienne Joanny

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE534394T1 publication Critical patent/ATE534394T1/de

Links

FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 3
229910052749 magnesium Inorganic materials 0.000 title abstract 3
239000011777 magnesium Substances 0.000 title abstract 3
239000002537 cosmetic Substances 0.000 title abstract 2
235000016709 nutrition Nutrition 0.000 title abstract 2
239000000419 plant extract Substances 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
239000000126 substance Substances 0.000 abstract 2
241000195493 Cryptophyta Species 0.000 abstract 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000003405 delayed action preparation Substances 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000000284 extract Substances 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
-1 fatty acid esters Chemical class 0.000 abstract 1
239000000945 filler Substances 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
229920001477 hydrophilic polymer Polymers 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
239000008101 lactose Substances 0.000 abstract 1
230000035764 nutrition Effects 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
150000004670 unsaturated fatty acids Chemical class 0.000 abstract 1
235000021122 unsaturated fatty acids Nutrition 0.000 abstract 1
239000012138 yeast extract Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Nutrition Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

AT04767183T 2003-05-27 2004-05-26 Kombination aus einem magnesiumpräparat mit verlängerter freisetzung und spezifischen pflanzenextrakten und verwendung in den bereichen kosmetik, therapeutika und/oder ernährung ATE534394T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0306411A FR2855412B1 (fr)	2003-05-27	2003-05-27	Composition a liberation prolongee de magnesium, et son application dans le domaine therapeutique, cosmetique et nutritionnel
PCT/FR2004/001305 WO2004105778A1 (fr)	2003-05-27	2004-05-26	Combinaison d’une preparation de magnesium a liberation prolongee et d’une autre substance active, utilisation dans le domaine cosmetique, therapeutique et/ou nutritionel

Publications (1)

Publication Number	Publication Date
ATE534394T1 true ATE534394T1 (de)	2011-12-15

Family

ID=33427470

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04767183T ATE534394T1 (de)	2003-05-27	2004-05-26	Kombination aus einem magnesiumpräparat mit verlängerter freisetzung und spezifischen pflanzenextrakten und verwendung in den bereichen kosmetik, therapeutika und/oder ernährung

Country Status (5)

Country	Link
US (1)	US20080031904A1 (de)
EP (1)	EP1633375B1 (de)
AT (1)	ATE534394T1 (de)
FR (1)	FR2855412B1 (de)
WO (1)	WO2004105778A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2931359B1 (fr)	2008-05-20	2012-12-21	Menvielle Bourg Fabienne Joanny	Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice
FR2931361B1 (fr)	2008-05-20	2012-08-31	Menvielle Bourg Fabienne Joanny	Systeme a base de magnesium et son utilisation en cosmetique
EP2813217A1 (de)	2013-06-11	2014-12-17	Fabienne Joanny Menvielle-Bourg	Zusammensetzung zur oralen Verabreichung von Magnesium in Verbindung mit einer Zusammensetzung zur Behandlung des Diabetes Typ 2 oder seiner Komplikationen
WO2015155245A1 (de)	2014-04-08	2015-10-15	Thüringisches Institut für Textil- und Kunststoff-Forschung e.V.	Cellulose-formkörper mit darin verteilten physiologisch wirksamen mineralstoffen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2296426A1 (fr) *	1975-01-03	1976-07-30	Durupt Marie Helene	Elixir
FR2616068A1 (fr) *	1987-06-04	1988-12-09	Phytland Sa Laboratoires	Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises
FI101344B1 (fi) *	1988-03-31	1998-06-15	Tanabe Seiyaku Co	Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
FR2677546B1 (fr) *	1991-06-12	1994-01-21	Fabienne Joanny	Composition therapeutique pour liberation prolonge de magnesium.
US5976568A (en) *	1997-02-21	1999-11-02	Medical Doctors' Research Institute, Inc.	Modular system of dietary supplement compositions for optimizing health benefits and methods

2003
- 2003-05-27 FR FR0306411A patent/FR2855412B1/fr not_active Expired - Fee Related
2004
- 2004-05-26 WO PCT/FR2004/001305 patent/WO2004105778A1/fr not_active Ceased
- 2004-05-26 AT AT04767183T patent/ATE534394T1/de active
- 2004-05-26 EP EP04767183A patent/EP1633375B1/de not_active Expired - Lifetime
2005
- 2005-11-23 US US11/286,192 patent/US20080031904A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1633375B1 (de)	2011-11-23
EP1633375A1 (de)	2006-03-15
FR2855412A1 (fr)	2004-12-03
FR2855412B1 (fr)	2007-05-25
WO2004105778A1 (fr)	2004-12-09
US20080031904A1 (en)	2008-02-07

Similar Documents

Publication	Publication Date	Title
KR101780658B1 (ko)	2017-09-21	콜라겐 산생 촉진 조성물
MX2009005299A (es)	2009-10-08	Maiz extraido con solvente.
KR102523943B1 (ko)	2023-04-20	신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염
EP2880989A1 (de)	2015-06-10	Futter für zuchtfische und verfahren zur wachstumsförderung von zuchtfischen damit
KR102387764B1 (ko)	2022-04-18	모낭 세포의 증식을 촉진시키는 이합체 형태의 펩타이드 유도체 또는 이의 염을 포함하는 탈모 예방 또는 치료용 조성물
TWI451879B (zh)	2014-09-11	Selected from the group consisting of D- alanine and D- hydroxy-proline, the above groups and D- alanine and proline salts of D- hydroxy consisting of one kind or two kinds of the compound for the production of laminin 332 the use of production accelerating composition
DE4315127A1 (de)	1994-11-10	Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
SA522431791B1 (ar)	2025-04-14	مركبات بيرازول، صياغات منها، وطريقة لاستخدام المركبات و/ أو صياغات
ATE534394T1 (de)	2011-12-15	Kombination aus einem magnesiumpräparat mit verlängerter freisetzung und spezifischen pflanzenextrakten und verwendung in den bereichen kosmetik, therapeutika und/oder ernährung
CN1032951C (zh)	1996-10-09	龟和鳖的组合物及其制备方法
DE69330268T2 (de)	2001-11-22	Hämoregulierende peptide
EP0979829B1 (de)	2004-06-16	Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Oligopeptiden zur Hautaufhellung von Altersflecken bzw. zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
CN104693274B (zh)	2018-03-06	一类昆虫抑咽侧体素的五肽类似物及其应用
KR20180020789A (ko)	2018-02-28	미녹시딜과 펩타이드의 결합체
DE112015004182T5 (de)	2018-01-11	Antimykotische Zusammensetzung umfassend antimykotisches Peptid und Terpenalkohol
JP2749871B2 (ja)	1998-05-13	魚類の養殖法および養魚用飼料
Neelima et al.	2022	Characterisation of a novel crustin isoform from mud crab, Scylla serrata (Forsskål, 1775) and its functional analysis in silico
JP4370411B2 (ja)	2009-11-25	育毛養毛剤、育毛養毛用毛髪化粧料および育毛養毛用医薬組成物
JP2018140947A (ja)	2018-09-13	コラーゲン産生の促進を特徴とする組成物およびリモノイド
CN113831399A (zh)	2021-12-24	短肽lbd-q在制备抗病毒感染产品中的应用、饲料及药物
Florence et al.	2013	Growth performance, survival rate and nutrient profile of Clarias gariepinus fingerlings fed rations of soybean as alternative protein source
KR102485194B1 (ko)	2023-01-06	LFRFamide 펩타이드를 유효성분으로 함유하는 복족류의 산란 유도용 조성물
KR101569773B1 (ko)	2015-11-17	아르테메터를 포함하는 모발 성장 촉진용 화장료 또는 약학 조성물
EP3239167A1 (de)	2017-11-01	Conotoxinpeptid-?-cptx-btl01, herstellungsverfahren dafür und verwendung davon
DE102006036887A1 (de)	2008-02-07	Zusammensetzung für ein Mittel zur Pflege, Wachstumsförderung, Stärkung und dergleichen von Haut, Haaren und Nägeln